| Literature DB >> 31142902 |
Mujgan Cengiz1, Esma Cezayirli2, Burcu Bayoglu1, Hizir Asliyuksek3, Nese Kocabasoglu4.
Abstract
BACKGROUND: Child sexual abuse (CSA) is an important problem worldwide. The reason of sex abuse is considered as multifactorial. Genetic contribution reported by recent studies is a significant evidence for this pathologic behavior. Catechol-O-Methyltransferase (COMT) is an enzyme in the metabolic inactivation of catecholamine and substances containing catecholamines such as dopamine, epinephrine, and norepinephrine. COMT polymorphism causes functional changes in COMT enzyme activity. Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor usually synthesized from central nervous system neurons. With the effect of BDNF, dopamine and serotonin play important roles on neurogenesis, survival, and synaptic plasticity. AIM: This study aims to examine COMT Val158Met (rs4680) and BDNF Val66Met (rs6265) polymorphisms in CSA. SETTINGS ANDEntities:
Keywords: Brain-derived neurotrophic factor; catechol-O-methyl transferase; paraphilia; polymorphism; sexual abuse
Year: 2019 PMID: 31142902 PMCID: PMC6532468 DOI: 10.4103/psychiatry.IndianJPsychiatry_194_18
Source DB: PubMed Journal: Indian J Psychiatry ISSN: 0019-5545 Impact factor: 1.759
Demographic and clinical characteristics of patients and controls
| Parameter | Patients | Controls | |
|---|---|---|---|
| Age (years), mean±SD | 30.46±11.78 | 31.91±12.19 | 0.493 |
| Gender (male), | 70 | 70 | |
| Alcohol or drug use | 15 | 10 | |
| Psychiatric disease | 45 | - |
SD – Standard deviation
Distribution of genotypes and allele frequencies of catechol-O-methyl transferase (Val158Met) in patients and controls
| COMT (Val158Met) | GG | GA | AA | G allele frequency | A allele frequency | ||
|---|---|---|---|---|---|---|---|
| Patients, | 22 (31.4) | 32 (45.7) | 16 (22.9) | 0.018 | 0.54 | 0.46 | 0.54 |
| Controls, | 17 (24.3) | 47 (67.1) | 6 (8.6) | 0.58 | 0.42 |
COMT – Catechol-O-methyl transferase
Genotypes and allele frequencies of brain-derived neurotrophic factor (Val66Met) in patients and controls
| BDNF (Val66Met) | GG | GA | AA | G allele frequency | A allele frequency | ||
|---|---|---|---|---|---|---|---|
| Patients, | 54 (77.1) | 15 (21.4) | 1 (1.4) | 0.317 | 0.88 | 0.12 | 0.13 |
| Controls, | 46 (65.7) | 22 (31.4) | 2 (2.9) | 0.81 | 0.19 |
BDNF – Brain-derived neurotrophic factor
Catechol-O-methyl transferase Val158Met genotype distribution according to clinical diagnosis
| COMT (Val158Met) | GG | GA | AA | |
|---|---|---|---|---|
| Personality disorder, | 0 (0.0) | 1 (50.0) | 1 (50.0) | 0.235 |
| Schizophrenia and other psychotic disorders, | 7 (58.3) | 3 (25.0) | 2 (16.7) | |
| Bipolar disorder, | 0 (0.0) | 3 (75.0) | 1 (25.0) | |
| Mental retardation, | 7 (25.9) | 11 (40.7) | 9 (33.3) |
COMT – Catechol-O-methyl transferase
Brain-derived neurotrophic factor genotype distribution according to clinical diagnosis
| BDNF (Val66Met) | GG | GA | AA | |
|---|---|---|---|---|
| Personality disorder, | 2 (100.0) | 0 (0.0) | 0 (0.0) | 0.797 |
| Schizophrenia and other psychotic disorders, | 9 (75.0) | 3 (25.0) | 0 (0.0) | |
| Bipolar disorder, | 4 (100.0) | 0 (0.0) | 0 (0.0) | |
| Mental retardation, | 23 (85.2) | 3 (11.1) | 1 (3.7) |
BDNF – Brain-derived neurotrophic factor